Literature DB >> 31378877

MicroRNA-449b-5p promotes the progression of osteoporosis by inhibiting osteogenic differentiation of BMSCs via targeting Satb2.

J-Y Li1, X Wei, Q Sun, X-Q Zhao, C-Y Zheng, C-X Bai, J Du, Z Zhang, L-G Zhu, Y-S Jia.   

Abstract

OBJECTIVE: We aimed to explore the role of microRNA-449b-5p in osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) and its mechanism of action.
MATERIALS AND METHODS: Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) assay was used to detect the expression levels of microRNA-449b-5p and osteogenic markers including RUNX2, OCN during BMSCs differentiation. The microRNA-449b-5p mimic and microRNA-449b-5p inhibitors were transfected into BMSCs to achieve microRNA-449b-5p overexpression and knockdown, then the expressions of osteogenic markers were detected by qRT-PCR. The ALP activity staining and the alizarin red staining were used to detect the activity of ALP and the mineralization ability of cells after overexpression and knockdown of microRNA-449b-5p. Binding sites for microRNA-449b-5p and Satb2 were predicted by TargetScan, the PicTar and microRNAanda programs, and confirmed by dual-luciferase reporter gene assay. The relationship between microRNA-449b-5p and Satb2 was analyzed by QRT-PCR and Western blot. The microRNA-449b-5p inhibitor and shSATB2 lentivirus were simultaneously transfected in BMSCs, and the expression levels of RUNX2, OCN and ALP were detected by qRT-PCR and ALP activity assays.
RESULTS: microRNA-449b-5p expression gradually decreased during osteogenic differentiation. Overexpression of microRNA-449b-5p inhibited BMSCs differentiation by down-regulating ALP activity, RUNX2, and OCN expression, while the opposite result was observed after knockdown of microRNA-449b-5p. MicroRNA-449b-5p can bind to the 3'UTR end of Satb2, which was involved in the osteogenic differentiation of microRNA-449b-5p-regulated BMSCs, and silencing of Satb2 can abolish the positive effect of the microRNA-449b-5p inhibitor on osteoblasts differentiation.
CONCLUSIONS: microRNA-449b-5p could aggravate osteoporosis by inhibiting osteogenic differentiation of BMSCs through targeting Satb2.

Entities:  

Year:  2019        PMID: 31378877     DOI: 10.26355/eurrev_201908_18519

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

1.  LncRNA BC083743 Silencing Exacerbated Osteoporosis by Regulating the miR-103-3p/SATB2 Axis to Inhibit Osteogenic Differentiation.

Authors:  Feng Lu; Ling Tang
Journal:  Comput Intell Neurosci       Date:  2022-06-20

Review 2.  The Role of Micro RNA and Long-Non-Coding RNA in Osteoporosis.

Authors:  Nai-Yu Ko; Li-Ru Chen; Kuo-Hu Chen
Journal:  Int J Mol Sci       Date:  2020-07-10       Impact factor: 5.923

Review 3.  SATB2: A versatile transcriptional regulator of craniofacial and skeleton development, neurogenesis and tumorigenesis, and its applications in regenerative medicine.

Authors:  Xia Huang; Qiuman Chen; Wenping Luo; Mikhail Pakvasa; Yuxin Zhang; Liwen Zheng; Shuang Li; Zhuohui Yang; Huan Zeng; Fang Liang; Fugui Zhang; Daniel A Hu; Kevin H Qin; Eric J Wang; David S Qin; Russell R Reid; Tong-Chuan He; Aravind Athiviraham; Mostafa El Dafrawy; Hongmei Zhang
Journal:  Genes Dis       Date:  2020-10-17

Review 4.  The Emerging Role of MicroRNAs in Bone Diseases and Their Therapeutic Potential.

Authors:  Luis Alberto Bravo Vázquez; Mariana Yunuen Moreno Becerril; Erick Octavio Mora Hernández; Gabriela García de León Carmona; María Emilia Aguirre Padilla; Samik Chakraborty; Anindya Bandyopadhyay; Sujay Paul
Journal:  Molecules       Date:  2021-12-30       Impact factor: 4.411

5.  miR-27b attenuates dexamethasone-inhibited proliferation and osteoblastic differentiation in MC3T3-E1 cells by targeting PPARγ2.

Authors:  Huicheng Lv; Tieyi Yang; Aimin He; Mingbo Wang; Haisheng Jia; Min Ma; Siqin Li
Journal:  Exp Ther Med       Date:  2021-12-10       Impact factor: 2.447

Review 6.  Osteoporosis pathogenesis and treatment: existing and emerging avenues.

Authors:  Shu Lin; Yan-Chuan Shi; Bo Liang; George Burley
Journal:  Cell Mol Biol Lett       Date:  2022-09-04       Impact factor: 8.702

Review 7.  The Role of MicroRNAs in Bone Metabolism and Disease.

Authors:  Yongguang Gao; Suryaji Patil; Airong Qian
Journal:  Int J Mol Sci       Date:  2020-08-24       Impact factor: 5.923

8.  Silencing of miR-483-5p alleviates postmenopausal osteoporosis by targeting SATB2 and PI3K/AKT pathway.

Authors:  Fujiang Zhao; Yier Xu; Yulong Ouyang; Zhexu Wen; Guihao Zheng; Ting Wan; Guicai Sun
Journal:  Aging (Albany NY)       Date:  2021-02-17       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.